Read + Share
Amedeo Smart
Independent Medical Education
Borras-Blasco J, Valcuende-Rosique A, Cornejo S. Letter to the editor regarding 'First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn's disease'. Eur J Gastroenterol Hepatol 2025;37:985-986.PMID: 40575883
Email
LinkedIn
Privacy Policy